SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector control

Molecular Attraction aims to evaluate the efficacy and environmental impact of innovative mosquito-specific semiochemicals in sub-Saharan Africa to enhance vector control and reduce disease burden.

Subsidie
€ 2.500.000
2023

Projectdetails

Introduction

Each year, chemicals worth €8bn are used for Mosquito Vector Control (MVC). Still, mosquito-borne diseases constitute a major socio-economic burden. As insecticides start losing efficacy and toxic chemicals are being banned from use (in the west in particular), we are becoming increasingly defenseless. By 2050, an additional 1bn people will be at risk of contracting at least one mosquito-borne disease due to the rapid expansion of habitats of mosquito vectors.

Company Overview

Molecular Attraction is a pioneer in mosquito-specific phagostimulants and pheromones. We can control mosquito behaviour using minute quantities of highly effective, affordable, and perfectly green semiochemicals.

Project Description

In the project, we will conduct a large-scale trial in sub-Saharan Africa to evaluate the following:

  1. Efficacy
  2. Cost-effectiveness
  3. Environmental impact of our unique blends.

The trial results will be leveraged to enter the global MVC market.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 4.171.988

Tijdlijn

Startdatum1-12-2023
Einddatum30-11-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • MOLECULAR ATTRACTION ABpenvoerder

Land(en)

Sweden

Inhoudsopgave

EIC Accelerator

EU-subsidieprogramma voor mkb en start-ups met grants tot €2,5 mln en equity-investeringen tot €15 mln voor baanbrekende innovaties.

Bekijk regeling

Vergelijkbare projecten binnen EIC Accelerator

ProjectRegelingBedragJaarActie

The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and Zika

ATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization.

EIC Accelerator€ 2.499.999
2023
Details

Using mineral carriers for pheromones to apply the ecologically friendly mating disruption method for protecting crops against pests on a large scale

Lithos' Micro Dispenser Technology uses natural zeolite to deliver targeted pheromone treatments for effective, safe, and sustainable pest control in agriculture.

EIC Accelerator€ 1.366.312
2022
Details
EIC Accelerator

The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and Zika

ATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization.

EIC Accelerator
€ 2.499.999
2023
Details
EIC Accelerator

Using mineral carriers for pheromones to apply the ecologically friendly mating disruption method for protecting crops against pests on a large scale

Lithos' Micro Dispenser Technology uses natural zeolite to deliver targeted pheromone treatments for effective, safe, and sustainable pest control in agriculture.

EIC Accelerator
€ 1.366.312
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

How has the rapid scale up of malaria control in Africa impacted vector competence?

This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options.

ERC Starting...€ 1.499.581
2023
Details

Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoes

This project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies.

ERC Starting...€ 1.500.000
2023
Details

More specific insecticides: harnessing knowledge of insect receptors

This project aims to develop species-specific insecticides using peptides targeting insect neurotransmitter receptors, ensuring safety for non-target organisms while exploring commercial viability.

ERC Proof of...€ 150.000
2023
Details

Mobile Bio-Lab to support first response in Arbovirus outbreaks

MOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs.

EIC Pathfinder€ 2.998.500
2023
Details

THERAPRO

Dit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen.

Mkb-innovati...€ 163.275
2019
Details
ERC Starting...

How has the rapid scale up of malaria control in Africa impacted vector competence?

This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options.

ERC Starting Grant
€ 1.499.581
2023
Details
ERC Starting...

Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoes

This project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies.

ERC Starting Grant
€ 1.500.000
2023
Details
ERC Proof of...

More specific insecticides: harnessing knowledge of insect receptors

This project aims to develop species-specific insecticides using peptides targeting insect neurotransmitter receptors, ensuring safety for non-target organisms while exploring commercial viability.

ERC Proof of Concept
€ 150.000
2023
Details
EIC Pathfinder

Mobile Bio-Lab to support first response in Arbovirus outbreaks

MOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs.

EIC Pathfinder
€ 2.998.500
2023
Details
Mkb-innovati...

THERAPRO

Dit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 163.275
2019
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.